Consistent with this hypothesis, the patient manifesting with late F‐NHL relapse originated from DLBCL with typical molecular and IHC profile of a GCB neoplasm with BCL2 but not MYC re‐arrangements. The gene discussed is BCL2; the disease is neoplasm.